Current Report — Form 8-K
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 8-K Axim Biotechnologies, Inc. - Form 8-K SEC Filing HTML 27K
2: EX-10.1 Form of Convertible Note Purchase Agreement Dated HTML 16K
March 15, 2024
3: EX-10.2 Form of Version 1 Note Dated March 15, 2024 HTML 25K
4: EX-10.3 Form of Version 2 Note Dated March 15, 2024 HTML 25K
5: EX-10.4 Form of Version 3 Note Dated March 15, 2024 HTML 24K
6: EX-10.5 Form of Stock Purchase Agreement Dated March 15, HTML 14K
2024
11: R1 Document and Entity Information HTML 43K
13: XML IDEA XML File -- Filing Summary XML 13K
16: XML XBRL Instance -- axim-20240315_htm XML 14K
12: EXCEL IDEA Workbook of Financial Report Info XLSX 6K
7: EX-101.DEF XBRL Definitions -- axim-20240315_def XML 10K
8: EX-101.LAB XBRL Labels -- axim-20240315_lab XML 64K
9: EX-101.PRE XBRL Presentations -- axim-20240315_pre XML 44K
10: EX-101.SCH XBRL Schema -- axim-20240315 XSD 12K
14: JSON XBRL Instance as JSON Data -- MetaLinks 16± 25K
15: ZIP XBRL Zipped Folder -- 0001096906-24-000539-xbrl Zip 36K
‘EXCEL’ — IDEA Workbook of Financial Report Info
This is an IDEA Workbook.
↑Top
Filing Submission 0001096906-24-000539 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Wed., May 15, 8:03:37.1pm ET